Human umbilical cord mesenchymal stem cell therapy (Bellastem Biotech)

人脐带间充质干细胞（山东兴瑞生物科技）

Report date: 2023/10/10 20:05:08

Base Information

Drug NameHuman umbilical cord mesenchymal stem cell therapy (Bellastem Biotech)
Drug Alias Name新邦干细胞
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBellastem Biotechnology Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBellastem Biotechnology Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A